The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1027
May 22, 1998
View Complete Issue         Table of Contents 2019 
Fenoldopam--A New Drug for Parenteral Treatment of Severe Hypertension
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Fenoldopam--A New Drug for Parenteral Treatment of Severe Hypertension
May 22, 1998 (Issue: 1027)
Fenoldopam mesylte (Corlopam - Neurex), a peripheral dopamine-1 (DA1) agonist, has been approved by the FDA for parenteral use in lowering blood pressure. The manufacturer claims that, unlike other parenteral antihypertensive agents, fenoldopam not...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Fenoldopam--A New Drug for Parenteral Treatment of Severe Hypertension
Article code: 1027b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.